TLPH FY 2024 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$7M

Operating Income

-$15M

Net Income

-$13M

EPS (Diluted)

$-0.50

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$989,000

Balance Sheet

Total Assets

$18M

Total Liabilities

$10M

Stockholders' Equity

$8M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$651,000	-100.0%
Gross Profit	-$7M	-$5M	-37.2%
Operating Income	-$15M	-$17M	+9.7%
Net Income	-$13M	-$18M	+29.3%